Pascal Chastagner
37PUBLICATIONS
287CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (37)
Sort by Publication Date:
|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff
|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.Juliet C Gray, Rebekah Weston, Cormac Owens
|Oct 04, 2025
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher
|Sep 25, 2025
Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France.Dana Al Khalifa, Pascal Chastagner, Gudrun Schleiermacher
|Sep 04, 2025
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and <sup>123</sup>ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center Study.Anna Borovkov, Juliette Assy, Isabelle Aerts
|Aug 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN Study.Julie Savagner, Caroline Munzer, Gudrun Schleiermacher
Pageof 7
Frequent Collaborators
9 joint publications
Gaelle Pierron
8 joint publications
Birgit Geoerger
7 joint publications
Olivier Delattre
6 joint publications
Didier Surdez
6 joint publications
Louis Chesler
5 joint publications
Valentina Boeva
5 joint publications
Anne-Sophie Defachelles
5 joint publications
Ruth Lydia Ladenstein
5 joint publications
Yasmine Iddir
4 joint publications
Isabelle Janoueix-Lerosey
